The Solubility Company

The Solubility Company’s proprietary SPATM technology produces vast amounts of drug physicochemical data for small molecules and peptides across a practically unlimited solute and solvent chemical space. In his role as Digital Business Advisor Jussi Hacklin will utilize his extensive experience to provide expert guidance and strategically support the commercialization of The Solubility Company’s SPATM drug property data.

Jussi Hacklin said: “I have always been excited by all aspects of digital business, especially the meeting point of the physical and digital world. I was attracted to The Solubility Company’s multidisciplinary approach for advanced drug analysis and the great purpose that the company serves. I look forward to helping The Solubility Company position its game-changing technology within the pharmaceutical market.”